HealthStream, Inc. $HSTM Stock: Copeland Capital Management LLC Cuts Position

Key Points

• Copeland Capital Management cut its HealthStream position by 2.5% in the third quarter, selling 31,148 shares and retaining 1.22 million shares valued at approximately $36.2 million. Institutional investors collectively own 69.58% of the company.
• HealthStream reported quarterly earnings of $0.23 per share, beating estimates of $0.17, while revenue of $83.73 million also exceeded expectations. The company pays a $0.14 annualized dividend, yielding about 0.4%.
• HSTM shares opened at $33.75, near their 52-week high of $34.48, while analysts maintained a consensus “Hold” rating with a $27 price target. CEO Robert Frist Jr. also sold 144,068 shares worth approximately $4.25 million.

Copeland Capital Management LLC trimmed its position in HealthStream, Inc. (NASDAQ:HSTM - Free Report) by 2.5% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,217,236 shares of the technology company's stock after selling 31,148 shares during the quarter. Copeland Capital Management LLC owned 4.17% of HealthStream worth $36,164,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of HSTM. MassMutual Private Wealth & Trust FSB lifted its position in HealthStream by 76.4% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,025 shares of the technology company's stock valued at $28,000 after buying an additional 444 shares in the last quarter. Integrated Wealth Concepts LLC purchased a new stake in HealthStream during the second quarter worth approximately $27,000. GAMMA Investing LLC grew its stake in HealthStream by 5.2% during the third quarter. GAMMA Investing LLC now owns 21,686 shares of the technology company's stock worth $644,000 after buying an additional 1,076 shares during the period. Global Retirement Partners LLC purchased a new stake in HealthStream during the second quarter worth approximately $31,000. Finally, Essential Partners LLC purchased a new stake in HealthStream during the first quarter worth approximately $25,000. 69.58% of the stock is owned by institutional investors and hedge funds.

HealthStream Stock Performance

Shares of NASDAQ:HSTM opened at $33.75 on Wednesday. The business's 50-day simple moving average is $29.55 and its 200 day simple moving average is $26.39. The company has a market cap of $986.17 million, a P/E ratio of 46.88, a PEG ratio of 3.87 and a beta of 0.42. HealthStream, Inc. has a one year low of $19.50 and a one year high of $34.48.

HealthStream (NASDAQ:HSTM - Get Free Report) last released its quarterly earnings results on Monday, August 3rd. The technology company reported $0.23 earnings per share for the quarter, topping analysts' consensus estimates of $0.17 by $0.06. The firm had revenue of $83.73 million during the quarter, compared to analysts' expectations of $80.82 million. HealthStream had a return on equity of 6.81% and a net margin of 6.60%. Analysts predict that HealthStream, Inc. will post 0.72 earnings per share for the current year.

HealthStream Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 28th. Investors of record on Monday, August 17th were paid a $0.0350 dividend. The ex-dividend date was Monday, August 17th. This represents a $0.14 annualized dividend and a dividend yield of 0.4%. HealthStream's payout ratio is 19.44%.

Insider Activity at HealthStream

In related news, CEO Robert Frist, Jr. sold 144,068 shares of the business's stock in a transaction dated Monday, September 14th. The stock was sold at an average price of $29.50, for a total value of $4,250,006.00. Following the transaction, the chief executive officer owned 3,907,038 shares in the company, valued at approximately $115,257,621. The trade was a 3.56% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 20.40% of the company's stock.

Analysts Set New Price Targets

A number of brokerages have recently commented on HSTM. Wall Street Zen raised shares of HealthStream from a "hold" rating to a "buy" rating in a research note on Sunday, August 30th. Canaccord Genuity Group upped their price target on shares of HealthStream from $24.00 to $27.00 and gave the stock a "hold" rating in a research report on Tuesday, July 21st. Finally, Weiss Ratings raised shares of HealthStream from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Thursday, October 8th. One equities research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, HealthStream has a consensus rating of "Hold" and a consensus price target of $27.00.

About HealthStream

HealthStream, Inc provides workforce solutions for the healthcare industry. The company develops software and services designed to help healthcare organizations manage employee learning, performance, credentialing, and other workforce-related processes.

Its offerings include online learning and education management, workforce development tools, competency and performance management, and credentialing solutions. HealthStream also provides content and administrative services intended to support regulatory compliance, professional development, and operational efficiency for healthcare employers.

Based in Nashville, Tennessee, HealthStream primarily serves healthcare organizations in the United States, including hospitals, health systems, medical practices, and other healthcare providers.

Want to see what other hedge funds are holding HSTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthStream, Inc. (NASDAQ:HSTM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.